Experiences with
Eylea214 public posts
Want to take advantage of all our features? Just log in!
or
Webinar: New approved treatment for wet AMD
He’ll also discuss how Lytenava compares to existing treatments, such as Eylea and Lucentis, its potential benefits, and what this approval means for NHS patients.
This webinar will be taking place at 7pm on Tuesday 18 February.
Not dying was a good plan, but how to navigate the future is the next challenge
Such as:
Eylea, for wet age-related macular degeneration
Praluent, for high cholesterol
Dupixent, for atopic dermatitis
Libtayo, for skin cancer
Regen-cov, for covid-19
They have a robust research pipeline with one branch focused on liver disease.
Webinar: Increased dose of Eylea to extend treatment intervals
A renowned retinal specialist based in the US, Dr Kenneth Fan will join us this month to discuss the increased dose of licensed drug Eylea (aflibercept) to treat wet age-related macular degeneration and diabetic macular oedema.